Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers

BACKGROUND: Methylated Septin 9 (SEPT9) is a sensitive biomarker for colorectal cancer (CRC) from peripheral blood. However, its relationship to cancer localization, guaiac-based fecal occult blood test (gFOBT) and carcinoembryonic antigen (CEA) have not been described. METHODOLOGY/PRINCIPAL FINDING...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tóth, Kinga, Sipos, Ferenc, Kalmár, Alexandra, Patai, Árpád V., Wichmann, Barnabás, Stoehr, Robert, Golcher, Henriette, Schellerer, Vera, Tulassay, Zsolt, Molnár, Béla
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3457959/
https://ncbi.nlm.nih.gov/pubmed/23049919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0046000
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados